Expanding the reach of highly potent cancer therapies with pre|CISION^®

We believe in hope
without compromise

The pre|CISION^® peptide drug conjugate platform. >

Avacta is seeking to expand its partnerships for targeted cancer therapies. >

Watch the videos from our Research & Development Spotlight Series  >